Please login to the form below

Not currently logged in
Email:
Password:

China

This page shows the latest China news and features for those working in and with pharma, biotech and healthcare.

Sanofi backs vaccines unit with €350m Canadian facility

Sanofi backs vaccines unit with €350m Canadian facility

The new Toronto plant will focus on making paediatric and booster vaccines that have been growing at a healthy lick, particularly in Europe and China, despite being pegged back of late

Latest news

More from news
Approximately 90 fully matching, plus 518 partially matching documents found.

Latest Intelligence

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    Colistin is considered the last line of defence against multidrug-resistant organisms and using it as an animal feed supplement is unacceptable and is already banned in China and Europe. ... Yet colistin resistance is already here and spreading worldwide.

  • Deal Watch January 2018

    Royalty monetisation. 230. Jiangsu Hengrui Medicine/Arcutis. SHR0302, selective JAK inhibitor, for dermatology disorders (currently p2 for RA in China).

  • A catalyst for change A catalyst for change

    A catalyst for change. China’s plan to boost innovation and improve drug accessibility. ... multinational companies to designate China as their first market when launching new products.

  • Risky business for pharma Risky business for pharma

    Risky business for pharma. China, Russia and Brazil are expected to provide the most issues. ... Global risk areas . China (22%), Russia (16%) and Brazil (16%) led the list of riskiest markets identified by surveyed executives from life science and

  • The ‘Million Hour Challenge’ The ‘Million Hour Challenge’

    Over 700, 000 hours saved for sales representatives in AstraZeneca China to focus on customers, through a combination of simplifying field data collection, improved territory and quota management, optimisation of external

More from intelligence
Approximately 13 fully matching, plus 97 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 33 partially matching documents found.

Latest from PMHub

  • Pharma China Annual Forum 2017

    Pharma China Annual Forum 2017. We are delighted to be presenting a paper at the Pharma China Annual Forum on 14th April 2017 in Shanghai, China. ... 00. The patient is an important stakeholder in the treatment of chronic conditions in urban China.

  • 12 Challenges Big Pharma Faces in China

    12 Challenges Big Pharma Faces in China. Published in eyeforpharma 16 November by Rachel Howard. ... www.researchpartnership.com/news/2015/11/article-12-challenges-big-pharma-faces-in-china/.

  • Webinar: Understanding the patient journey in China

    Webinar: Understanding the patient journey in China. The Chinese healthcare market is experiencing a period of great change. ... Identify the opportunities and challenges associated with the healthcare reforms. Learn how to ensure that your market

  • Ageing Asia: What does this mean for the future of healthcare?

    Ageing Asia: What does this mean for the future of healthcare? Over the last 30 years, Asia’ s economic growth has resulted in improved education and healthcare across a broad base of the population. This has contributed to declining fertility and

  • Ageing in China: The Implications for Healthcare

    Ageing in China: The Implications for Healthcare. Published in eye for pharma 12 December by Marc Yates. ... Traditionally, the majority of elderly care in China has been provided by families.

More from PMHub
Approximately 10 fully matching, plus 68 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics